Five Prime Therapeutics, Inc. Marketable Securities (Current)
Five Prime Therapeutics, Inc. had Marketable Securities (Current) of $217.84 million as of 2020-12-31, per its 10-K filed 2021-03-22.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2021-03-22
- 2020-12-31: Marketable Securities, Current $217.84M.
- 2020-09-30: Marketable Securities, Current $75.35M.
- 2020-06-30: Marketable Securities, Current $68.35M.
- 2020-03-31: Marketable Securities, Current $73.44M.
| Period end | Marketable Securities, Current |
|---|---|
| 2020-12-31 | $217.84M 10-K · filed 2021-03-22 |
| 2020-09-30 | $75.35M 10-Q · filed 2020-11-03 |
| 2020-06-30 | $68.35M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $73.44M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $100.58M 10-K · filed 2021-03-22 |
| 2019-09-30 | $137.05M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $175.82M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $207.32M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $226.19M 10-K · filed 2020-02-27 |
| 2018-09-30 | $257.55M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $299.98M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $323.49M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $232.90M 10-K · filed 2019-02-26 |
| 2017-09-30 | $284.31M 10-Q · filed 2017-11-06 |
| 2017-06-30 | $291.01M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $333.13M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $414.10M 10-K · filed 2018-02-27 |
| 2016-09-30 | $384.32M 10-Q · filed 2016-11-04 |
| 2016-06-30 | $431.07M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $348.98M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $367.50M 10-K · filed 2017-02-24 |
| 2015-09-30 | $146.46M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $188.31M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $202.66M 10-Q · filed 2015-05-14 |
| 2014-12-31 | $133.79M 10-K · filed 2016-03-11 |
| 2014-09-30 | $116.85M 10-Q · filed 2014-11-12 |
| 2014-06-30 | $127.52M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $117.25M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $67.56M 10-K · filed 2015-03-18 |
| 2013-09-30 | $8.99M 10-Q · filed 2013-11-13 |
| 2012-12-31 | $26.62M 10-K · filed 2014-03-26 |